<VariationArchive VariationID="505021" VariationName="NM_003924.4(PHOX2B):c.753_767dup (p.Ala256_Ala260dup)" VariationType="Duplication" Accession="VCV000505021" Version="12" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2018-04-09" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="496319" VariationID="505021">
      <GeneList>
        <Gene Symbol="LOC110011216" FullName="paired like homeobox 2b polyalanine repeat instability region" GeneID="110011216" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>4p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="41745975" stop="41746028" display_start="41745975" display_stop="41746028" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PHOX2B" FullName="paired like homeobox 2B" GeneID="8929" HGNC_ID="HGNC:9143" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>4p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="41744082" stop="41748725" display_start="41744082" display_stop="41748725" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="41746098" stop="41750986" display_start="41746098" display_stop="41750986" Strand="-" />
          </Location>
          <OMIM>603851</OMIM>
          <Haploinsufficiency last_evaluated="2024-07-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PHOX2B">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2024-07-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PHOX2B">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003924.4(PHOX2B):c.753_767dup (p.Ala256_Ala260dup)</Name>
      <CanonicalSPDI>NC_000004.12:41745984:GCCGCTGCCGCCGCCGCCGCTGCCGC:GCCGCTGCCGCCGCCGCCGCTGCCGCCGCCGCCGCTGCCGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>4p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="41745984" stop="41745985" display_start="41745984" display_stop="41745985" variantLength="15" positionVCF="41745984" referenceAlleleVCF="T" alternateAlleleVCF="TGCCGCTGCCGCCGCC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="41748001" stop="41748002" display_start="41748001" display_stop="41748002" variantLength="15" positionVCF="41748001" referenceAlleleVCF="T" alternateAlleleVCF="TGCCGCTGCCGCCGCC" />
      </Location>
      <OtherNameList>
        <Name>NM_003924.4(PHOX2B):c.753_767dup</Name>
        <Name>p.Ala256_Ala260dup</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_513" sequenceAccession="LRG_513">
            <Expression>LRG_513:g.7972_7986dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.41748013_41748027dup" Assembly="GRCh37">
            <Expression>NC_000004.11:g.41748013_41748027dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.41745996_41746010dup" Assembly="GRCh38">
            <Expression>NC_000004.12:g.41745996_41746010dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008243.1" sequenceAccession="NG_008243" sequenceVersion="1" change="g.7972_7986dup">
            <Expression>NG_008243.1:g.7972_7986dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053075.1" sequenceAccession="NG_053075" sequenceVersion="1" change="g.122_136dup">
            <Expression>NG_053075.1:g.122_136dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003924.4" sequenceAccession="NM_003924" sequenceVersion="4" change="c.753_767dup" MANESelect="true">
            <Expression>NM_003924.4:c.753_767dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003915.2" sequenceAccession="NP_003915" sequenceVersion="2" change="p.Ala256_Ala260dup">
            <Expression>NP_003915.2:p.Ala256_Ala260dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_513t1" sequenceAccession="LRG_513t1">
            <Expression>LRG_513t1:c.753_767dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_513p1" sequenceAccession="LRG_513p1" change="p.Ala256_Ala260dup">
            <Expression>LRG_513p1:p.Ala256_Ala260dup</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003924.3" sequenceAccession="NM_003924" sequenceVersion="3" change="c.753_767dupGGCGGCGGCAGCGGC">
            <Expression>NM_003924.3:c.753_767dupGGCGGCGGCAGCGGC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA501224" DB="ClinGen" />
        <XRef Type="rs" ID="779557320" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003924.4(PHOX2B):c.753_767dup (p.Ala256_Ala260dup) AND Congenital central hypoventilation" Accession="RCV000615033" Version="4">
        <ClassifiedConditionList TraitSetID="1663">
          <ClassifiedCondition DB="MedGen" ID="C1275808">Congenital central hypoventilation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-05-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003924.4(PHOX2B):c.753_767dup (p.Ala256_Ala260dup) AND Hereditary cancer-predisposing syndrome" Accession="RCV002395543" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003924.4(PHOX2B):c.753_767dup (p.Ala256_Ala260dup) AND not provided" Accession="RCV003139903" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003924.4(PHOX2B):c.753_767dup (p.Ala256_Ala260dup) AND Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease" Accession="RCV003983142" Version="2">
        <ClassifiedConditionList TraitSetID="79161">
          <ClassifiedCondition DB="MedGen" ID="C5562075">Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-12" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-04-09" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general" Abbrev="ATS, 2010">
          <ID Source="PubMed">20208042</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12640453</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14566559</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14608649</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15121777</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15334515</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26063465</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/a1de1601-72ec-456c-88be-407e308b6937</URL>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301600</ID>
          <ID Source="BookShelf">NBK1427</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="79161" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="65666" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 1</ElementValue>
                <XRef Type="MIM" ID="209880" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603851.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603851.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603851.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603851.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603851.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603851.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603851.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease</ElementValue>
                <XRef ID="MONDO:0800026" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AUTONOMIC CONTROL, CONGENITAL FAILURE OF</ElementValue>
                <XRef Type="MIM" ID="209880" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ONDINE CURSE, CONGENITAL</ElementValue>
                <XRef Type="MIM" ID="209880" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CCHS1</ElementValue>
                <XRef Type="MIM" ID="209880" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Congenital central hypoventilation syndrome (CCHS) represents the extreme manifestation of autonomic nervous system dysregulation (ANSD) with the hallmark of disordered respiratory control. The age of initial recognition of CCHS ranges from neonatal onset (i.e., in the first 30 days of life) to (less commonly) later onset (from 1 month to adulthood). Neonatal-onset CCHS is characterized by apparent hypoventilation with monotonous respiratory rates and shallow breathing either during sleep only or while awake as well as asleep; ANSD including decreased heart rate beat-to-beat variability and sinus pauses; altered temperature regulation; and altered pupillary response to light. Some children have altered development of neural crest-derived structures (i.e., Hirschsprung disease, altered esophageal motility/dysphagia, and severe constipation even in the absence of Hirschsprung disease) and/or tumors of neural crest origin (neuroblastoma, ganglioneuroma, and ganglioneuroblastoma). Neurocognitive delay is variable, and possibly influenced by cyanotic breath holding, prolonged sinus pauses, need for 24-hour/day artificial ventilation, and seizures. Later-onset CCHS is characterized by alveolar hypoventilation during sleep and attenuated manifestations of ANSD.</Attribute>
                <XRef ID="NBK1427" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8535" />
                <XRef ID="8535" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301600</ID>
                <ID Source="BookShelf">NBK1427</ID>
              </Citation>
              <XRef ID="661" DB="Orphanet" />
              <XRef ID="C5562075" DB="MedGen" />
              <XRef ID="MONDO:0800026" DB="MONDO" />
              <XRef Type="MIM" ID="209880" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1663" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="576" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital central hypoventilation</ElementValue>
                <XRef ID="399040002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital Central Hypoventilation Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Idiopathic congenital central alveolar hypoventilation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital failure of autonomic control</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Primary alveolar hypoventilation</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8535" />
                <XRef ID="8535" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="274">gain of function</Attribute>
                <XRef ID="GTR000510954" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562004" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528367" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510469" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510972" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502996" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551868" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510951" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510968" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510969" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521924" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556815" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510955" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510965" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510957" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510468" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528368" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519456" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510930" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510956" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Congenital central hypoventilation syndrome (CCHS) represents the extreme manifestation of autonomic nervous system dysregulation (ANSD) with the hallmark of disordered respiratory control. The age of initial recognition of CCHS ranges from neonatal onset (i.e., in the first 30 days of life) to (less commonly) later onset (from 1 month to adulthood). Neonatal-onset CCHS is characterized by apparent hypoventilation with monotonous respiratory rates and shallow breathing either during sleep only or while awake as well as asleep; ANSD including decreased heart rate beat-to-beat variability and sinus pauses; altered temperature regulation; and altered pupillary response to light. Some children have altered development of neural crest-derived structures (i.e., Hirschsprung disease, altered esophageal motility/dysphagia, and severe constipation even in the absence of Hirschsprung disease) and/or tumors of neural crest origin (neuroblastoma, ganglioneuroma, and ganglioneuroblastoma). Neurocognitive delay is variable, and possibly influenced by cyanotic breath holding, prolonged sinus pauses, need for 24-hour/day artificial ventilation, and seizures. Later-onset CCHS is characterized by alveolar hypoventilation during sleep and attenuated manifestations of ANSD.</Attribute>
                <XRef ID="NBK1427" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301600</ID>
                <ID Source="BookShelf">NBK1427</ID>
              </Citation>
              <Citation Type="general" Abbrev="ATS, 2010">
                <ID Source="PubMed">20208042</ID>
              </Citation>
              <XRef ID="661" DB="Orphanet" />
              <XRef ID="99803" DB="Orphanet" />
              <XRef ID="C1275808" DB="MedGen" />
              <XRef ID="MONDO:0800031" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS209880" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1393201" SubmissionDate="2019-03-21" DateLastUpdated="2018-04-09" DateCreated="2018-04-09">
        <ClinVarSubmissionID localKey="68579755|Orphanet:ORPHA661" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000712095" DateUpdated="2018-04-09" DateCreated="2018-04-09" Type="SCV" Version="2" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-05-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15334515</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20208042</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12640453</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14608649</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26063465</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14566559</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301600</ID>
          </Citation>
          <Comment>The p.Ala241[25] variant in PHOX2B is a well-established pathogenic variant for CCHS, which has been reported in &gt;100 affected individuals and was absent from ~ 4000 control chromosomes tested across multiple studies (Weese-Mayer 2010). This variant is a 15bp duplication within a polyalanine tract in exon 3 of the PHOX2 B gene, resulting in an expansion to a total of 25 alanine residues. It frequent ly occurs de novo, though autosomal dominant inheritance and somatic mosaicism h ave also been reported (Weese-Mayer 2010). While this variant typically causes c ongenital central hypoventilation, it has also been reported in individuals that presented with disease in infancy or childhood, raising the possibility of dela yed onset (Weese-Mayer 2010, Shimokaze 2015). In summary, this variant meets our criteria to be classified as pathogenic for CCHS in an autosomal dominant manne r.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHOX2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_003924.3:EXON 3</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_003924.3:c.753_767dup</Name>
            <Name>p.Ala260_Gly261insAlaAlaAlaAlaAla</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.41748001_41748002insGCCGCTGCCGCCGCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA661" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348979</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7128608" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="6beccff829d08ba2ed106975d1f3999dfa8f959a80b5345f2e526c2530d78a1e|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003822852" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003924.4:c.753_767dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8883212" SubmissionDate="2024-03-13" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="a1de1601-72ec-456c-88be-407e308b6937" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004800932" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/a1de1601-72ec-456c-88be-407e308b6937</URL>
          </Citation>
          <Comment>The heterozygous p.Ala256_Ala260dup variant in PHOX2B was identified by our study in one individual with Marcus Gunn jaw-winking synkinesis with congenital ptosis, central hypoventilation, and Hirschsprung disease, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Engle lab (https://kirbyneuro.org/EngleLab/). Trio genome analysis showed this variant to be de novo. We believe this is a possible phenotype expansion for congenital central hypoventilation syndrome-1 with or without Hirschsprung disease. The p.Ala256_Ala260dup variant in PHOX2B has been previously reported in over 100 individuals with congenital central hypoventilation syndrome 1 with or without Hirschsprung disease (PMID: 22437207, PMID: 26063465, PMID: 14608649, PMID: 29531718, PMID: 15121777, PMID: 14566559, PMID: 15334515, PMID: 12640453, SCV001244958.1, SCV001792209.1) and segregated with disease in at least 8 affected relatives from 5 families (PMID: 22437207, PMID: 14608649). The number of reported affected individuals with this variant is greater than expected compared to non-affected individuals with this variant. This variant was found to be de novo in at least 10 individuals with confirmed paternity and maternity (PMID: 15121777, PMID: 15334515, PMID: 12640453, SCV001244958.1, SCV001792209.1) and is assumed de novo in 1 individual, but maternity and paternity have not been confirmed (PMID: 29531718). This variant was absent from large population studies. This variant has also been reported in ClinVar (Variation ID: 505021, 429242, 988333) and has been interpreted as pathogenic by Ambry Genetics and Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant congenital central hypoventilation syndrome-1 with or without Hirschsprung disease. ACMG/AMP Criteria applied: PS2_VeryStrong, PS4, PM2_Supporting, PP1_Strong (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHOX2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_003924.4(PHOX2B):c.753_767dup</Name>
            <Name>p.Ala256_Ala260dup</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.12:g.41745996_41746010dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0800026" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14307097</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5157371" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a651243|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002672010" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12640453</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15121777</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20208042</ID>
          </Citation>
          <Comment>The p.Ala241[25] pathogenic mutation, located in coding exon 3 of the PHOX2B gene, results from an expansion of the polyalanine repeat region from 20 to 25 repeats. This expansion mutation is associated with congenital central hypoventilation syndrome (Amiel J et al. Nat. Genet., 2003 Apr;33:459-61; Matera I et al. J. Med. Genet., 2004 May;41:373-80; Weese-Mayer DE et al. Am. J. Respir. Crit. Care. Med. 2010 Mar;181(6):626-44). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHOX2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003924.3:c.753_767dupGGCGGCGGCAGCGGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1393201" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA661" MappingRef="Orphanet">
        <MedGen CUI="C5562075" Name="Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5157371" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7128608" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8883212" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0800026" MappingRef="MONDO">
        <MedGen CUI="C5562075" Name="Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2024-04-25">SCV001445533</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

